Hemogenyx Pharmaceuticals (UK) Analysis

Hemogenyx Stock Analysis Notes

The book value of the company was currently reported as 0.0. The company recorded a loss per share of 2.0. Hemogenyx Pharmaceuticals had not issued any dividends in recent years. The entity had 1:400 split on the 13th of December 2024. To learn more about Hemogenyx Pharmaceuticals PLC call Vladislav Sandler at 44 79 0917 7311 or check out https://hemogenyx.com.

Hemogenyx Pharmaceuticals Investment Alerts

Hemogenyx Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemogenyx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hemogenyx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Hemogenyx Pharmaceuticals has return on total asset (ROA) of (0.3779) % which means that it has lost $0.3779 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5597) %, meaning that it generated substantial loss on money invested by shareholders. Hemogenyx Pharmaceuticals' management efficiency ratios could be used to measure how well Hemogenyx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hemogenyx Pharmaceuticals' Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 9.4 M in 2024, whereas Total Current Assets are likely to drop slightly above 2.1 M in 2024.

Technical Drivers

As of the 22nd of December, Hemogenyx Pharmaceuticals retains the Standard Deviation of 8.04, market risk adjusted performance of 0.4359, and Risk Adjusted Performance of (0.04). Hemogenyx Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Hemogenyx Pharmaceuticals information ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk to decide if Hemogenyx Pharmaceuticals is priced fairly, providing market reflects its last-minute price of 343.4 per share.

Hemogenyx Pharmaceuticals Price Movement Analysis

Hemogenyx Pharmaceuticals Outstanding Bonds

Hemogenyx Pharmaceuticals Predictive Daily Indicators

Hemogenyx Pharmaceuticals Forecast Models

Hemogenyx Pharmaceuticals' time-series forecasting models are one of many Hemogenyx Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hemogenyx Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hemogenyx Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hemogenyx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hemogenyx Pharmaceuticals. By using and applying Hemogenyx Stock analysis, traders can create a robust methodology for identifying Hemogenyx entry and exit points for their positions.

When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.